Pediatric delamanid treatment for children with rifampicin-resistant TB

Int J Tuberc Lung Dis. 2022 Oct 1;26(10):986-988. doi: 10.5588/ijtld.22.0264.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Child
  • Humans
  • Nitroimidazoles* / therapeutic use
  • Oxazoles / therapeutic use
  • Rifampin / therapeutic use
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • Rifampin